Track topics on Twitter Track topics that are important to you
Rather than hone the killer instincts of immune cells—and risk unleashing an overzealous horde—cancer immunotherapies may recruit and train nonimmune cells, which have the potential to be more controllable. Alternatively, cancer immunotherapies could assemble antitumor units consisting of both engineered immune cells, such as chimeric antigen receptor T (CAR-T) cells, and engineered nonimmune cells, including cells outfitted with “synthetic T-cell receptor–like signal transduction devices.” If given the right kit, even a soft cell—an adipose stem cell, for example—could join the anticancer fight, suggests a team of scientists based at ETH Zurich. This team, led by Martin Fussenegger, Ph.D., a professor of biotechnology and bioengineering, reports that it can equip nonimmune cells with additional components, and muster ranks of synthetic designer cells that mimic T cells. Details appeared November 13 in the journal Nature Chemical Biology , in an article entitled, “Nonimmune cells equipped with T-cell-receptor–like signaling for ...
Original Article: Cancer Immunotherapies May Deploy Nonimmune Cells Engineered to a "T"NEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...